GL1X · GenesisL1 explorer

MolNFT v1 · #144210 · protein

Non-receptor protein tyrosine phosphatase SHP2 in complex with allosteric inhibitor SHP244

6BMR · Tyrosine-protein phosphatase non-receptor type 11: “Non-receptor protein tyrosine phosphatase SHP2 in complex with allosteric inhibitor SHP244”. X-ray diffraction, 2 ligands (DZV, PO4), 14 pockets (best druggability 0.68). MolNFT v1…

PDB
6BMR
Type
protein
Length
970 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein phosphatase non-receptor type 11
EC
3.1.3.48
UniProt
Q06124
Ligands
DZV, PO4
Pockets
14 · best druggability 0.68

Structure

x-ray diffraction · 2 distinct chains · 31% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein48930% helix, 27% strandQ06124
BTyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein48131% helix, 26% strandQ06124

Ligands and binding sites

  • DZV · 4-[(2-chlorophenyl)methyl]-1-(2-hydroxy-3-methoxyphenyl)[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one · ligand · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · 8 copies · chains A, B
  • GOL · Glycerol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18220.680.7565empty
24040.640.7834PO4
33540.630.7933empty
41260.540.8221empty
51520.530.8023PO4

Interfaces

1 interface between chains.

  • A–B · 162 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 6BMR · Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor SHP244 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.